The targets of this miRNA are the different key genes involved in insulin signaling, insulin resistance, fatty acid, triglyceride, lipoprotein and cholesterol biosynthesis and NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.